MedTrace Logo

Registry of Device Implantation

NCT03360227 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2020-02-07

No results posted yet for this study

Summary

The implantable device therapy for cardiac arrhythmias has been an established therapy, and one of the common standard procedures in cardiac clinical practice.

Pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy have been developed since 1960s, and the technologies in this field are still progressively developing. Not only these "traditional" implantable devices, there are multiple new devices for cardiac diseases, such as implantable loop recorder, vagal nerve stimulator and barostimulator.

The aim of this registry is to demonstrate the efficacy and the safety of standard device implantation procedures and to evaluate/ identify specific factors, including clinical characteristics, laboratory data and procedural data, which predict the prognosis/complication of the patients. These identification will result in further improvement of patients' care.

Conditions

  • Syncope
  • Bradycardia
  • Tachycardia
  • Sudden Cardiac Death
  • Ventricular Tachycardia
  • Ventricular Fibrillation

Interventions

DEVICE

implantation of cardiac devices

implantation of cardiac devices

Sponsors & Collaborators

  • Klinik für Kardiologie, Pneumologie und Angiologie

    lead OTHER

Principal Investigators

  • Hisaki Makimoto, MD · Division of Cardiology, Pulmonary Disease and Vascular Medicine

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03360227 on ClinicalTrials.gov